DupixentTM is an antibody directed against the α subunit of the interleukin 4 receptor (IL-4R-α) [88], and the TezsipreTM blocks thymic stromal lymphopoietin (TSLP), which plays a key role in asthma [89,90]. The gene discussed is IL4R; the disease is asthma.